{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:11:42Z","timestamp":1793225502290,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s12026-020-09117-9","type":"journal-article","created":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T03:03:07Z","timestamp":1583290987000},"page":"48-53","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["The case for severe combined immunodeficiency (SCID) and T cell lymphopenia newborn screening: saving lives\u2026one at a time"],"prefix":"10.1007","volume":"68","author":[{"given":"Jessica","family":"Quinn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan S.","family":"Orange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicki","family":"Modell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3764-0242","authenticated-orcid":false,"given":"Fred","family":"Modell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,4]]},"reference":[{"key":"9117_CR1","unstructured":"Merrill D. No one values your life more than the Federal Government. Bloomberg October 19, 2017. https:\/\/www.bloomberg.com\/graphics\/2017-value-of-life\/. Accessed 2 March 2018."},{"key":"9117_CR2","unstructured":"Miller J. The high cost of preventable deaths. June 4, 2018. https:\/\/hms.harvard.edu\/news\/high-cost-preventable-deaths"},{"key":"9117_CR3","volume-title":"Immune deficiency disorders: types","author":"A Mullen","year":"2019","unstructured":"Mullen A. Immune deficiency disorders: types. Denver: National Jewish Health; 2019. https:\/\/www.nationaljewish.org\/conditions\/immune-deficiency-disorders\/types"},{"key":"9117_CR4","doi-asserted-by":"publisher","unstructured":"Amatuni GS, Currier RJ, Church JA, Bishop T, Grimbacher E, Nguyen AA, et al. Newborn Screening for Severe Combined Immunodeficiency and T-cell Lymphopenia in California, 2010\u20132017. Pediatrics. 2019;143(2). https:\/\/doi.org\/10.1542\/peds.2018-2300.","DOI":"10.1542\/peds.2018-2300"},{"issue":"7","key":"9117_CR5","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1056\/NEJM199902183400703","volume":"340","author":"RH Buckley","year":"1999","unstructured":"Buckley RH, Schiff SE, Schif RI, et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med. 1999;340(7):508\u201316.","journal-title":"N Engl J Med"},{"key":"9117_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12026-010-8191-9","volume":"49","author":"RH Buckley","year":"2011","unstructured":"Buckley RH. Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: longterm outcomes. Immunol Res. 2011;49:25\u201343.","journal-title":"Immunol Res"},{"key":"9117_CR7","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1182\/blood.V99.3.872","volume":"99","author":"LA Myers","year":"2002","unstructured":"Myers LA, Patel DD, Puck JM, Buckley RH. Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival. Blood. 2002;99:872\u20138.","journal-title":"Blood."},{"key":"9117_CR8","doi-asserted-by":"publisher","unstructured":"Kwan A, Abraham RS, Currier R, Brower A, Andruszewski K, Abbott JK, et al. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA. 2014 August 20;312(7):729\u201338. https:\/\/doi.org\/10.1001\/jama.2014.9132.","DOI":"10.1001\/jama.2014.9132"},{"issue":"5","key":"9117_CR9","doi-asserted-by":"publisher","first-page":"1062\u20139.e1\u20134","DOI":"10.1016\/j.jaci.2009.08.041","volume":"124","author":"NC Patel","year":"2009","unstructured":"Patel NC, et al. Outcomes of severe combined immunodeficiency patients treated with hematopoietic stem cell transplantation with and without pre-conditioning. J Allergy Clin Immunol. 2009;124(5):1062\u20139.e1\u20134.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"9117_CR10","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s10875-015-0152-6","volume":"35","author":"J van der Spek","year":"2015","unstructured":"van der Spek J, Groenwold RH, van der Burg M, van Montfrans JM. TREC based newborn screening for severe combined immunodeficiency disease: a systematic review. J Clin Immunol. 2015;35(4):416\u201330. https:\/\/doi.org\/10.1007\/s10875-015-0152-6.","journal-title":"J Clin Immunol"},{"issue":"3","key":"9117_CR11","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jaci.2012.01.032","volume":"129","author":"JM Puck","year":"2012","unstructured":"Puck JM. Laboratory technology for population-based screening for severe combined immunodeficiency in neonates: the winner is T-cell receptor excision circles. J Allergy Clin Immunol. 2012;129(3):607\u201316. https:\/\/doi.org\/10.1016\/j.jaci.2012.01.032.","journal-title":"J Allergy Clin Immunol"},{"key":"9117_CR12","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1172\/JCI200423571","volume":"114","author":"RH Buckley","year":"2004","unstructured":"Buckley RH. The multiple causes of human SCID. J Clin Investig. 2004;114:1409\u201311.","journal-title":"J Clin Investig"},{"key":"9117_CR13","doi-asserted-by":"publisher","unstructured":"Pai SY, Logan BR, Griffith LM, Buckley RH, Parrott RE, Dvorak CC, et al. Transplantation outcomes for severe combined immunodeficiency, 2000\u20132009. N Engl J Med. 2014;371:434\u201346. https:\/\/doi.org\/10.1056\/NEJMoa1401177.","DOI":"10.1056\/NEJMoa1401177"},{"issue":"17","key":"9117_CR14","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1182\/blood-2018-03-840702","volume":"132","author":"Haddad","year":"2018","unstructured":"Haddad, et al. SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery. Blood. 2018;132(17):1737\u201349. https:\/\/doi.org\/10.1182\/blood-2018-03-840702.","journal-title":"Blood."},{"key":"9117_CR15","volume-title":"Universal newborn screening for severe combined immunodeficiency (SCID). [PowerPoint]","author":"M Baker","year":"2012","unstructured":"Baker M. Universal newborn screening for severe combined immunodeficiency (SCID). [PowerPoint]. APHL CDC Newborn Screening Molecular Workshop: Atlanta; 2012."},{"key":"9117_CR16","doi-asserted-by":"publisher","unstructured":"Korsunskiy I, Blyuss O, Gordukova M, Davydova N, Gordleeva S, Molchanov R, et al. TREC and KREC levels as a predictors of lymphocyte subpopulations measured by flow Cytometry. Front Physiol. 2019;9:1877. https:\/\/doi.org\/10.3389\/fphys.2018.01877.","DOI":"10.3389\/fphys.2018.01877"},{"key":"9117_CR17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3389\/fped.2019.00373","volume":"7","author":"M van der Burg","year":"2019","unstructured":"van der Burg M, Mahlaoui N, Gaspar HB, Pai S-Y. Universal newborn screening for severe combined immunodeficiency (SCID). Front Pediatr. 2019;7:373. https:\/\/doi.org\/10.3389\/fped.2019.00373.","journal-title":"Front Pediatr"},{"key":"9117_CR18","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.3389\/fimmu.2017.01470","volume":"8","author":"MS Thakar","year":"2017","unstructured":"Thakar MS, Hintermeyer MK, Gries MG, Routes JM, Verbsky JW. A practical approach to newborn screening for severe combined immunodeficiency using the T cell receptor excision circle assay. Front Immunol. 2017;8:1470. https:\/\/doi.org\/10.3389\/fimmu.2017.01470.","journal-title":"Front Immunol"},{"key":"9117_CR19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/ijns3020014","volume":"3","author":"MT Bausch-Jurken","year":"2017","unstructured":"Bausch-Jurken MT, Verbsky JW, Routes JM. Newborn screening for severe combined immunodeficiency-a history of the TREC assay. Int J Neonatal Screen. 2017;3:14. https:\/\/doi.org\/10.3390\/ijns3020014.","journal-title":"Int J Neonatal Screen"},{"key":"9117_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/ijns3020013","volume":"3","author":"E Rechavi","year":"2017","unstructured":"Rechavi E, Lev A, Saraf-Levy T, Etzioni A, Almashanu S, Somech R. Newborn screening for severe combined immunodeficiency in Israel. Int J Neonatal Screen. 2017;3:13. https:\/\/doi.org\/10.3390\/ijns3020013.","journal-title":"Int J Neonatal Screen"},{"key":"9117_CR21","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2147\/CLEP.S48890","volume":"5","author":"BT Kelly","year":"2013","unstructured":"Kelly BT, Tam JS, Verbsky JW, Routes JM. Screening for severe combined immunodeficiency in neonates. Clin Epidemiol. 2013;5:363\u20139. Published 2013 Sep 16. https:\/\/doi.org\/10.2147\/CLEP.S48890.","journal-title":"Clin Epidemiol"},{"key":"9117_CR22","doi-asserted-by":"publisher","unstructured":"Adams SP, Rashid S, Premachandra T, Harvey K, Ifederu A, Wilson MC, et al. Screening of neonatal UK dried blood spots using a duplex TREC screening assay. J Clin Immunol. 2014;34:323\u201330. https:\/\/doi.org\/10.1007\/s10875-014-0007-6.","DOI":"10.1007\/s10875-014-0007-6"},{"key":"9117_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/ijns3020015","volume":"3","author":"M Dorsey","year":"2017","unstructured":"Dorsey M, Puck J. Screening for severe combined immunodeficiency in the US: current status and approach to management. Int J Neonatal Screen. 2017;3:15.","journal-title":"Int J Neonatal Screen"},{"key":"9117_CR24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s12026-014-8485-4","volume":"60","author":"V Modell","year":"2014","unstructured":"Modell V, Knaus M, Modell F. An analysis and decision tool to measure cost benefit of newborn screening for severe combined immunodeficiency (SCID) and related T-cell lymphopenia. Immunol Res. 2014;60:145\u201352. https:\/\/doi.org\/10.1007\/s12026-014-8485-4.","journal-title":"Immunol Res"},{"issue":"3","key":"9117_CR25","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.ymgme.2011.07.007","volume":"104","author":"K Chan","year":"2011","unstructured":"Chan K, Davis J, Pai SY, Bonilla FA, Puck JM, Apkon M. A Markov model to analyze cost-effectiveness of screening for severe combined immunodeficiency (SCID). Mol Genet Metab. 2011;104(3):383\u20139.","journal-title":"Mol Genet Metab"},{"key":"9117_CR26","doi-asserted-by":"publisher","unstructured":"Lipstein EA, Vorono S, Browning MF, Green NS, Kemper AR, Knapp AA, et al. Systematic evidence review of newborn screening and treatment of severe combined immunodeficiency. Pediatrics. 2010;125(5):e1226\u201335. https:\/\/doi.org\/10.1542\/peds.2009-1567.","DOI":"10.1542\/peds.2009-1567"},{"key":"9117_CR27","unstructured":"Hospital Cost and Utilization Project (HCUP), Nationwide Inpatient Database under the auspices of the Agency for Healthcare Research and Quality (AHRQ). ICD-9 CM Principal Diagnosis Code for HSCT."},{"key":"9117_CR28","unstructured":"Centers for Medicare and Medicaid Services, Hospital Accounting Records, April 28, 2010."},{"key":"9117_CR29","doi-asserted-by":"publisher","unstructured":"Kubiak C, Jyonouchi S, Kuo C, Garcia-Lloret M, Dorsey MJ, Sleasman J, et al. Fiscal implications of newborn screening in the diagnosis of severe combined immunodeficiency. J Allergy Clin Immunol Pract. 2014;2(6):697\u2013702. https:\/\/doi.org\/10.1016\/j.jaip.2014.05.013.","DOI":"10.1016\/j.jaip.2014.05.013"},{"key":"9117_CR30","unstructured":"Caggana M, Brower A, Baker M, Comeau AM, Lorey F. National SCID Pilot Study http:\/\/preview.tinyurl.com\/lsanbqh."},{"issue":"16","key":"9117_CR31","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1001\/jama.2010.1485","volume":"304","author":"BM Kuehn","year":"2010","unstructured":"Kuehn BM. State, federal efforts under way to identify children with \u201cbubble boy syndrome\u201d. JAMA. 2010;304(16):1771\u20133.","journal-title":"JAMA."},{"key":"9117_CR32","unstructured":"Appelbaum B. As US Agencies put more value on a life, businesses fret [newspaper]. New York Times, February 16, 2011. http:\/\/tinyurl.com\/mlynth7. Accessed 16 Aug 2013."},{"key":"9117_CR33","unstructured":"CBCNews Canada. \u2018Bubble boy\u2019 welcomes new Ontario screening test. Published online Aug 20, 2013. http:\/\/www.cbc.ca\/news\/canada\/story\/2013\/08\/20\/newborn-screening-bubble-boyscid.html. Accessed 21 Aug 2013."},{"key":"9117_CR34","unstructured":"Immunodeficiency Canada. Newborn Screening For SCID. https:\/\/immunodeficiency.ca\/newborn-screening-for-scid\/. Accessed Sept 19, 2019."},{"key":"9117_CR35","unstructured":"Direct communication with Public Health Officials and Jeffrey Modell Centers Network Directors."},{"key":"9117_CR36","doi-asserted-by":"crossref","unstructured":"Routes JM, Grossman WJ, Verbsky J, Laessig RH, Hoffman GL, Brokopp CD, et al. Statewide newborn screening for severe T-cell lymphopenia. JAMA. 2009;302(22):2465\u201370.","DOI":"10.1001\/jama.2009.1806"},{"issue":"9357","key":"9117_CR37","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S0140-6736(03)12513-5","volume":"361","author":"C Antoine","year":"2003","unstructured":"Antoine C, Muller S, Cant A, et al. Long-term survival and transplantation of hemopoietic stem cells for immunodeficiencies; report of the European experience 1986\u20131999. Lancet. 2003;361(9357):553\u201360.","journal-title":"Lancet."},{"key":"9117_CR38","doi-asserted-by":"crossref","unstructured":"Hassan A, Booth C, Brightwell A, Allwood Z, Veys P, Rao K, et al. Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency. Blood. 2012;120(17):3615\u201324.","DOI":"10.1182\/blood-2011-12-396879"},{"key":"9117_CR39","doi-asserted-by":"publisher","unstructured":"Kwan A, Church JA, Cowan MJ, Agarwal R, Kapoor N, Kohn DB, et al. Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: results of the first 2 years. J Allergy Clin Immunol. 2013;132(1):140\u201350. https:\/\/doi.org\/10.1016\/j.jaci.2013.04.024.","DOI":"10.1016\/j.jaci.2013.04.024"},{"key":"9117_CR40","unstructured":"The University of Texas Health Science Center at San Antonio (UTHSCSA). National newborn screening status report. November 21, 2011. http:\/\/genes-r-us.uthscsa.edu."}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-020-09117-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12026-020-09117-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-020-09117-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T01:24:42Z","timestamp":1614821082000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12026-020-09117-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["9117"],"URL":"https:\/\/doi.org\/10.1007\/s12026-020-09117-9","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"4 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest except for the following:Jordan Orange, MD, PhD, Takeda Consultant, Enzyvant Consultant, received speaking honoraria from Takeda, ADMA Scientific Advisory Board, author and editor in immunology for Up To Date receiving royalties.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}